Please ensure Javascript is enabled for purposes of website accessibility

Why LifeMD Stock Is Plunging Today

By Prosper Junior Bakiny - Updated Apr 19, 2021 at 1:02PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's shares are falling despite stellar preliminary first-quarter revenue results.

What happened

Shares of telehealth services provider LifeMD (LFMD 1.47%) are falling sharply on Monday and were down by 12.7% as of 1:49 p.m. EDT, after dropping by as much as 18.8% earlier in the day. These losses are a bit surprising: The company released better-than-expected preliminary first-quarter results this morning, so one might expect that its stock would be moving in the opposite direction. Perhaps we can attribute LifeMD's woes on the market today to a shareholder class action lawsuit against the company filed by Pennsylvania-based law firm Kaskela Law. 

So what

Understanding the basis for Kaskela Law's class action lawsuit requires a bit of background information. On April 14, investigative research firm Culper Research made serious accusations against LifeMD in a short-seller report. Specifically, Culper Research alleged that LifeMD and its executives are engaged in fraudulent and criminal business activities.

Five downward-bound arrows on a blackboard.

Image source: Getty Images.

Following the release of this report, shares of LifeMD dropped by almost 25% in one day. On April 17, Kaskela Law announced the filing of a class action lawsuit against LifeMD on behalf of "investors who have suffered an investment loss in excess of $100,000" following Culper Research's short-seller report. In an open letter posted on the company's website, LifeMD responded to -- and denied -- the allegations brought forth by Culper Research.

Now what

Despite the drama linked to Culper Research's short-seller report, LifeMD's business seems to be doing well. For the first quarter, the company expects revenue of $18.2 million, which is above the consensus analyst estimate of $17.01 million. This revenue figure would also represent year-over-year top-line growth of 323%. The healthcare company attributes this performance to strong retention and new patient acquisition.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

LifeMD, Inc. Stock Quote
LifeMD, Inc.
LFMD
$2.07 (1.47%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.